List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 37 studies with search of: Aldesleucina OR Proleukin [TREATMENT] AND HIV [CONDITION]
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed An International Study to Evaluate Anti-HIV Therapy Plus Interleukin-2 (rIL-2) in HIV Positive Patients
Condition: HIV Infections
Intervention: Drug: Aldesleukin
2 Completed A Phase I Study of Subcutaneously Administered Proleukin (Aldesleukin) in HIV-Infected Patients
Condition: HIV Infections
Intervention: Drug: Aldesleukin
3 Completed A Phase I Study of the Safety of Proleukin (Aldesleukin) in Combination With Ganciclovir and Antiretroviral Therapy in HIV Seropositive Patients With Cytomegalovirus (CMV) Retinitis
Conditions: Cytomegalovirus Retinitis;   HIV Infections
Intervention: Drug: Aldesleukin
4 Active, not recruiting Effect of Intermittent Aldesleukin Treatment With or Without Anti-HIV Drugs in HIV Infected People
Condition: HIV Infections
Intervention: Drug: Aldesleukin
5 Completed A Study to Evaluate the Effects of Giving Proleukin (rIL-2) to HIV-Positive Patients With CD4 Counts Greater Than 300 Cells/mm3
Condition: HIV Infections
Intervention: Drug: Aldesleukin
6 Completed Interleukin-2 Plus Antiretroviral Therapy for HIV-Infected Patients With Low CD4+ Counts (SILCAAT Study)
Condition: HIV Infection
Intervention: Drug: Proleukin
7 Active, not recruiting Interleukin-2 With and Without Antiretroviral Therapy to Treat HIV-1 Infection
Conditions: HIV Infections;   HIV
Intervention: Drug: Interleukin-2, Proleukin
8 Not yet recruiting A Study to Evaluate the Use of a Protease Inhibitor and of Interleukin-2 (IL-2) in the Treatment of Early HIV Infection
Condition: HIV Infections
Interventions: Drug: Indinavir sulfate;   Drug: Ritonavir;   Drug: Abacavir sulfate;   Drug: Efavirenz;   Drug: Stavudine;   Drug: Didanosine;   Drug: Aldesleukin
9 Completed A Phase II Study of Intermittent Recombinant Human Interleukin-2 (rhIL-2) by Intravenous or Subcutaneous Administration in Subjects With HIV Infection on Highly Active Antiretroviral Therapy (HAART) Compared to HAART Alone
Condition: HIV Infections
Interventions: Drug: Indinavir sulfate;   Drug: Lamivudine;   Drug: Stavudine;   Drug: Zidovudine;   Drug: Didanosine;   Drug: Aldesleukin
10 Active, not recruiting Subcutaneously Administered Aldesleukin ( Interleukin-2; IL-2 ) Therapy in HIV-Infected Patients
Condition: HIV Infections
Intervention: Drug: Aldesleukin
11 Completed The Effects of Giving Interleukin-2 (IL-2) Plus Anti-HIV Therapy to HIV-Positive Patients With CD4 Cell Counts of at Least 350 Cells/mm3
Condition: HIV Infections
Intervention: Drug: Aldesleukin
12 Active, not recruiting Effects of Giving Interleukin-2 (IL-2) Plus Anti-HIV Therapy to HIV-Positive Patients With CD4 Cell Counts of at Least 350 Cells/mm3
Condition: HIV Infections
Interventions: Drug: Aldesleukin;   Drug: ART
13 Completed A Study to Evaluate the Effects of Giving Interleukin-2 (IL-2) Plus Anti-HIV Therapy to HIV-Positive Patients With CD4 Cell Counts of at Least 350 Cells/mm3
Condition: HIV Infections
Intervention: Drug: Aldesleukin
14 Completed Immune Therapies and Anti-HIV Therapy Withdrawal in Controlling Viral Load
Condition: HIV Infections
Interventions: Biological: ALVAC(2)120(B,MN)GNP (vCP1452);   Drug: Aldesleukin
15 Completed Safety and Effectiveness of Adding Either an HIV Vaccine, Interleukin-2, or Both to a Patient's Anti-HIV Drug Combination
Condition: HIV Infections
Interventions: Biological: ALVAC(2)120(B,MN)GNP (vCP1452);   Drug: Aldesleukin
16 Active, not recruiting Safety and Effectiveness of L2-7001 (Interleukin-2) in HIV-Positive Patients Receiving Anti-HIV Therapy
Condition: HIV Infections
Intervention: Drug: Aldesleukin
17 Completed Effect of Interleukin-2 on HIV Treatment Interruption
Condition: HIV Infections
Intervention: Drug: Aldesleukin
18 Completed A Study to Evaluate the Effects of Giving IL-2 Alone to HIV-Positive Patients With CD4 Cell Counts of at Least 350 Cells/mm3 Who Do Not Wish to Receive Anti-HIV Therapy
Condition: HIV Infections
Intervention: Drug: Aldesleukin
19 Completed Interleukin-2 (IL-2), Pegylated Interferon (PEG-IFN Alfa-2b), and Ribavirin (RBV) Treatment in Patients With Hepatitis C and HIV Coinfection
Conditions: HIV Infections;   Hepatitis C
Interventions: Drug: Ribavirin;   Drug: Aldesleukin;   Drug: Peginterferon alfa-2b
20 Completed Safety and Efficacy of BAY 50-4798 in Patients With HIV Infection
Condition: HIV Infections
Interventions: Drug: Interleukin-2 SA;   Drug: HAART

Previous Page Studies Shown (1-20) Next Page (21-37)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services